Group One Trading’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$201K Sell
8,600
-400
-4% -$8.69K ﹤0.01% 4103
2025
Q4
$189K Buy
9,000
+4,000
+80% +$69.8K ﹤0.01% 4418
2025
Q3
$76.9K Sell
5,000
-3,200
-39% -$41.9K ﹤0.01% 5574
2025
Q2
$76.8K Buy
8,200
+7,500
+1,071% +$82.5K ﹤0.01% 5206
2025
Q1
$8.6K Buy
700
+100
+17% +$1.41K ﹤0.01% 6357
2024
Q4
$7.93K Sell
600
-39,600
-99% -$678K ﹤0.01% 6213
2024
Q3
$774K Buy
40,200
+38,700
+2,580% +$800K ﹤0.01% 2517
2024
Q2
$30.8K Sell
1,500
-42,100
-97% -$881K ﹤0.01% 4901
2024
Q1
$1.04M Sell
43,600
-23,000
-35% -$513K ﹤0.01% 2053
2023
Q4
$1.44M Sell
66,600
-648,600
-91% -$9.97M ﹤0.01% 2135
2023
Q3
$10.4M Buy
715,200
+703,300
+5,910% +$13.3M 0.03% 511
2023
Q2
$249K Buy
11,900
+2,400
+25% +$50K ﹤0.01% 3713
2023
Q1
$201K Sell
9,500
-1,900
-17% -$47.3K ﹤0.01% 3671
2022
Q4
$290K Buy
+11,400
New +$266K ﹤0.01% 3525
2022
Q2
Sell
-100
Closed -$2K 8480
2022
Q1
$2K Hold
100
﹤0.01% 7751
2021
Q4
$2K Buy
+100
New +$1.85K ﹤0.01% 7906
2021
Q3
Sell
-6,300
Closed -$108K 8746
2021
Q2
$108K Buy
6,300
+6,200
+6,200% +$114K ﹤0.01% 5873
2021
Q1
$2K Hold
100
﹤0.01% 7398
2020
Q4
$2K Sell
100
-12,500
-99% -$259K ﹤0.01% 6269
2020
Q3
$186K Buy
12,600
+5,000
+66% +$76.2K ﹤0.01% 3706
2020
Q2
$113K Buy
7,600
+6,700
+744% +$102K ﹤0.01% 3803
2020
Q1
$10K Sell
900
-9,300
-91% -$87.3K ﹤0.01% 4576
2019
Q4
$90K Buy
10,200
+5,200
+104% +$38.2K ﹤0.01% 3707
2019
Q3
$37K Sell
5,000
-1,000
-17% -$9.11K ﹤0.01% 4120
2019
Q2
$56K Buy
6,000
+1,700
+40% +$12.4K ﹤0.01% 3713
2019
Q1
$23K Hold
4,300
﹤0.01% 3963
2018
Q4
$19K Sell
4,300
-12,000
-74% -$65.8K ﹤0.01% 4048
2018
Q3
$132K Buy
16,300
+15,300
+1,530% +$109K ﹤0.01% 3325
2018
Q2
$7K Buy
1,000
+500
+100% +$4.91K ﹤0.01% 4731
2018
Q1
$7K Sell
500
-500
-50% -$5.31K ﹤0.01% 4428
2017
Q4
$9K Buy
+1,000
New +$9.9K ﹤0.01% 4415

Other funds holding SNDX